News | May 15, 2023
Advanced Enzyme Technologies posts Q4 FY23 consolidated PAT up at Rs. 32.12 Cr
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
Alembic has reported total income of Rs. 39.15 crores during the period ended March 31, 2023
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Subscribe To Our Newsletter & Stay Updated
